Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders

Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders

US Patent 7632836 · Granted Dec 15, 2009

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of cent2011
Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers2006
Calcium channel blockers2002
Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers2002
Substituted diarylalkyl amides as calcium channel antagonists2002
Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agen2002
Method for preventing and treating alcoholism2002
Peptidyl calcium channel blockers2002
Reduced dipeptide analogues as calcium channel antagonitsts2002
Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agen2002
Tyrosine-derived compounds as calcium channel antagonists2001
Reduced dipeptide analogues as calcium channel antagonists2001